| Literature DB >> 33330961 |
Selçuk Öztürk1,2, Ayşe Eser Elçin3, Yaşar Murat Elçin4,5.
Abstract
Myocardial infarction (MI) and heart failure (HF) are significant contributors of mortality worldwide. Mesenchymal stem cells (MSCs) hold a great potential for cardiac regenerative medicine-based therapies. Their therapeutic potential has been widely investigated in various in-vitro and in-vivo preclinical models. Besides, they have been tested in clinical trials of MI and HF with various outcomes. Differentiation to lineages of cardiac cells, neovascularization, anti-fibrotic, anti-inflammatory, anti-apoptotic and immune modulatory effects are the main drivers of MSC functions during cardiac repair. However, the main mechanisms regulating these functions and cross-talk between cells are not fully known yet. Increasing line of evidence also suggests that secretomes of MSCs and/or their extracellular vesicles play significant roles in a paracrine manner while mediating these functions. This chapter aims to summarize and highlight cardiac repair functions of MSCs during cardiac repair.Entities:
Keywords: Anti-fibrotic effect; Cardiac repair; Differentiation; Extracellular vesicles; Heart failure; Immune modulation; Mesenchymal stem cells; Myocardial infarction; Neovascularization; Paracrine function
Year: 2021 PMID: 33330961 DOI: 10.1007/5584_2020_598
Source DB: PubMed Journal: Adv Exp Med Biol ISSN: 0065-2598 Impact factor: 2.622